Now accepting applications 🚨
The Ionis Cardiometabolic Young Investigator Grant supports early-career researchers advancing severe #hypertriglyceridemia.
📩 Learn more: https://ionis.com/about-us/grants-and-sponsorships
#Cardiology #Research #EarlyCareer #Hypertriglyceridemia #CardioSky #MedSky
Now accepting applications 🚨 The Ionis Cardiometabolic Young Investigator Grant supports early-career researchers advancing severe #hypertriglyceridemia.
📩 Learn more: https://ionis.com/about-us/grants-and-sponsorships
#Cardiology #Research #EarlyCareer #Hypertriglyceridemia #CardioSky #MedSky
| Efficacy and safety of #antisenseoligonucleotide therapies targeting APoC-III in patients with severe #hypertriglyceridemia: a meta-analysis of randomized controlled trials | doi.org/10.4081/mona... | #openaccess #academicsky #medsky |
An oral #compound was developed to lower #BloodTriglycerides by selectively inhibiting #LiverXReceptor in the #liver and #gut, offering a potential treatment for high triglyceride-related diseases.
#Triglycerides #Hypertriglyceridemia #Dyslipidemia
TLR7 F507S gain-of-function mutation presenting with early-onset #SLE and #hypertriglyceridemia: Response to JAK inhibition. New report from Nima Parvaneh, Vahid Ziaee and colleagues (Tehran University of Medical Sciences): rupress.org/jhi/article/...
#Autoinflammation #InbornErrorsOfImmunity
Parvaneh, Ziaee et al. present a patient harboring the TLR7 F507S mutation who initially presented with refractory #thrombocytopenia that evolved into #SLE with subtle neurologic features, accompanied by #hypertriglyceridemia. rupress.org/jhi/article/...
#Autoimmunity #InbornErrorsOfImmunity
In @jhumimmunity.org, Parvaneh, Ziaee et al. present a patient harboring the TLR7 F507S mutation who initially presented with refractory #thrombocytopenia that evolved into #SLE with subtle neurologic features, accompanied by #hypertriglyceridemia. rupress.org/jhi/article/...
#Autoimmunity
#MedNews - Treatment with #olezarsen may significantly reduce triglyceride levels and result in fewer acute #pancreatitis events among adults with severe #hypertriglyceridemia.
👉 buff.ly/UGgiUQY
#CardioSky
From #ESCCongress 2025 - Dr. Brian Bergmark outlines the ESSENCE-TIMI 73b trial investigating #olezarsen in patients with moderate #hypertriglyceridemia and high cardiovascular risk.
Watch the full interview here 👉 buff.ly/cm1SuCn
#CardioSky #CVD
'Plasmapheresis for Hypertriglyceridemia-induced Acute Pancreatitis: A Systematic Review and Meta-summary of Case Reports' - a #JaypeeJournals 'Preventive and Emergency Medicine Insights' publication on #ScienceOpen:
🖇️ #Hypertriglyceridemia #AcutePancreatitis #Plasmapheresis #CriticalCare
It’s #TrigTriviaTuesday! 💥
Pancreatitis risk doesn’t wait—so here’s your quick quiz:
At what TG level does risk really spike?
A) >250 mg/dL
B) >500 mg/dL
C) >1,000 mg/dL
D) >2,000 mg/dL
Drop your guess & let’s talk TGs + pancreatitis ⬇️
#TrigTriviaTuesday #Hypertriglyceridemia #MedEd
Free Webinar – July 1 at 12PM ET
Join Dr. Seth J. Baum + Dr. James A. Underberg to gain insights into diagnosing + managing Severe Hypertriglyceridemia
🧠 Insightful. 🔍 Practical. 💬 Live Q&A.
📍 Register: nta.ampstream.io/nta1
@nattgalliance.bsky.social
#SevereHTG #Hypertriglyceridemia #CardioSky
us02web.zoom.us/webinar/regi...
#Lipids #Hypertriglyceridemia #triglycerides #CVD #cardiovasculardisease
Screenshot of Table 1: ACMG/AMP-based criteria considered for variant pathogenicity assessment
Implementing the #ACMG/AMP guidelines is no simple task. Study offers a #pathogenicity assessment of genetic #variants found in patients with severe #hypertriglyceridemia, shedding light on the diagnosis of #familialchylomicronemiasyndrome bit.ly/3DKXbjk
Effects of #hypertriglyceridemia with or without NEFA elevation on β-cell function and #insulin clearance and sensitivity: new Featured study in #JCEM. #FreeToView
#T2D #FattyAcids #lipids #BetaCell #diabetes
@endocrinesociety.bsky.social
doi.org/10.1210/clin...
Hemophagocytic Lymphohistiocytosis
🔹Life-threatening syndrome of overwhelming inflammation
🔹Is crucial to search and treat the underlying trigger
🚩Fever, #Splenomegaly, #Cytopenia, #hyperferritinemia, #hypertriglyceridemia, bone marrow #hemophagocytosis
#HLH
@nejm.org
www.nejm.org/doi/pdf/10.1...
In a Phase 2b trial, Olezarsen, targeting APOC3, significantly reduced triglycerides in patients (levels 150-499 mg/dL) at high cardiovascular risk. Exciting results for #hypertriglyceridemia! #cardiovascularhealth PMID:38587249, N Engl J Med 2024